Crosstalk and communication of cancer-associated fibroblasts with natural killer and dendritic cells: New frontiers and unveiled opportunities for cancer immunotherapy.

Cancer associated fibroblast (CAFs) Cell-cell interaction Dendritic Cells Immunotherapy Natural Killer Cells Solid tumors Stromal Cell Therapy Tumor microenvironment

Journal

Cancer treatment reviews
ISSN: 1532-1967
Titre abrégé: Cancer Treat Rev
Pays: Netherlands
ID NLM: 7502030

Informations de publication

Date de publication:
15 Oct 2024
Historique:
received: 27 08 2024
revised: 11 10 2024
accepted: 13 10 2024
medline: 24 10 2024
pubmed: 24 10 2024
entrez: 23 10 2024
Statut: aheadofprint

Résumé

Natural killer (NK) cells and dendritic cells (DCs) are critical mediators of anti-cancer immune responses. In addition to their individual roles, NK cells and DCs are involved in intercellular crosstalk which is essential for the initiation and coordination of adaptive immunity against cancer. However, NK cell and DC activity is often compromised in the tumor microenvironment (TME). Recently, much attention has been paid to one of the major components of the TME, the cancer-associated fibroblasts (CAFs), which not only contribute to extracellular matrix (ECM) deposition and tumor progression but also suppress immune cell functions. It is now well established that CAFs support T cell exclusion from tumor nests and regulate their cytotoxic activity. In contrast, little is currently known about their interaction with NK cells, and DCs. In this review, we describe the interaction of CAFs with NK cells and DCs, by secreting and expressing various mediators in the TME of adult solid tumors. We also provide a detailed overview of ongoing clinical studies evaluating the targeting of stromal factors alone or in combination with immunotherapy based on immune checkpoint inhibitors. Finally, we discuss currently available strategies for the selective depletion of detrimental CAFs and for a better understanding of their interaction with NK cells and DCs.

Identifiants

pubmed: 39442289
pii: S0305-7372(24)00171-3
doi: 10.1016/j.ctrv.2024.102843
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

102843

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Simone Ielpo (S)

Department of Clinical Sciences and Translational Medicine, University of Rome Tor Vergata, Rome, Italy.

Francesca Barberini (F)

Department of Clinical Sciences and Translational Medicine, University of Rome Tor Vergata, Rome, Italy.

Farnaz Dabbagh Moghaddam (F)

Institute for Photonics and Nanotechnologies, National Research Council, Via Fosso del Cavaliere, 100, Rome, Italy.

Silvia Pesce (S)

Department of Experimental Medicine and Centre of Excellence for Biomedical Research, University of Genoa, Genoa, Italy; IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Chiara Cencioni (C)

Institute for Systems Analysis and Computer Science "A. Ruberti", National Research Council (IASI-CNR), Rome, Italy.

Francesco Spallotta (F)

Department of Biology and Biotechnologies Charles Darwin, Sapienza University, 00185, Rome, Italy; Pasteur Institute Italy-Fondazione Cenci Bolognetti, Italy.

Adele De Ninno (A)

Institute for Photonics and Nanotechnologies, National Research Council, Via Fosso del Cavaliere, 100, Rome, Italy.

Luca Businaro (L)

Institute for Photonics and Nanotechnologies, National Research Council, Via Fosso del Cavaliere, 100, Rome, Italy.

Emanuela Marcenaro (E)

Department of Experimental Medicine and Centre of Excellence for Biomedical Research, University of Genoa, Genoa, Italy; IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Roberto Bei (R)

Department of Clinical Sciences and Translational Medicine, University of Rome Tor Vergata, Rome, Italy.

Loredana Cifaldi (L)

Department of Clinical Sciences and Translational Medicine, University of Rome Tor Vergata, Rome, Italy. Electronic address: cifaldi@med.uniroma2.it.

Giovanni Barillari (G)

Department of Clinical Sciences and Translational Medicine, University of Rome Tor Vergata, Rome, Italy.

Ombretta Melaiu (O)

Department of Clinical Sciences and Translational Medicine, University of Rome Tor Vergata, Rome, Italy. Electronic address: Ombretta.Melaiu@uniroma2.it.

Classifications MeSH